Certified by Founder Lodge
Outpace Bio
United States - Seattle, Washington
START UP
1 Disclosed Funding Rounds $144,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that over
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 02 ,2024 | Series B | $144,000,000 |
Mubadala Capital
Qatar Investment Authority
Alexandria Real Estate Equities, Inc.
Washington Research Foundation
Sahsen Ventures, LLC
Civilization Ventures
ARTIS Ventures
Bristol Myers Squibb
Surveyor Capital
Black Opal Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
